Skip to content

Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study

Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00642044
Enrollment
100
Registered
2008-03-24
Start date
2007-02-28
Completion date
2009-12-31
Last updated
2008-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Keywords

Keratoconus

Brief summary

Cross-linking of the cornea increases the mechanical and biochemical stability of the stromal tissue. The purpose of this study is to assess the effectiveness of riboflavin-ultraviolet light induced cross-linking of corneal collagen in improving visual acuity and reducing progression of keratoconus in the Brazilian population.

Interventions

UV light and Riboflavin eyedrops every 5 minutes for 30 minutes.

Sponsors

Universidade Federal do Rio de Janeiro
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Age from 18 to 35 years. * Diagnosis of Keratoconus. * Progression of Ametropia. * Written informed consent.

Exclusion criteria

* Corneal Thickness \< 395 micra at thinnest point. * Other active ocular disease than keratectasia. * Cornea Guttata. * Previous ocular surgery. * Pregnancy. * Known sensitivity to riboflavin.

Design outcomes

Primary

MeasureTime frame
Keratometry3 months
BSCVA (Best spectacle corrected visual acuity)3 months

Secondary

MeasureTime frame
Endothelial cell count3 months

Countries

Brazil

Contacts

Primary ContactRicardo Lamy, MD
lamy@ufrj.br55-21-2714-7646

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026